COMPARISON OF THE EFFECTIVENESS OF TOPICAL GLYCERINE MAGNESIUM SULPHATE PASTE Vs HEPARINOID (THROMBOPHOB) OINTMENT ON PHLEBITIS AMONG PATIENTS ON PERIPHERAL INTRAVENOUS THERAPY.

Comparison of the effectiveness of topical Glycerine Magnesium Sulphate paste vs heparinoid (thrombophob) ointment on phlebitis among patients on peripheral intravenous therapy.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/013888

Enrollment

100

Registered

2018-05-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Reduction in phlebitis and pain within 24hours using magnesium sulphate paste application.

Interventions

Intervention1: Glycerine Magnesium Sulphate: Glycerine Magnesium Sulphate Paste : 1 Finger Tip Unit (FTU), Local Application, Twice a day for 2 days Control Intervention1: Thrombophob(Heparinoid) Oint

Eligibility

Inclusion criteria

Inclusion criteria: -Patients who developed phlebitis only in the upper limb with visual infusion phlebitis score of two or more. -Patients who are 18 to 65 years old. -Patients with infusion-related phlebitis and not received any form of intervention by a staff nurse. -Patients who can speak Tamil, English, Hindi, and Telugu.

Exclusion criteria

Exclusion criteria: -Patients who are allergic to Glycerine Magnesium Sulphate paste or heparinoid (thrombophob) ointment. -Patients on central venous catheter on the same side of the limb, dermatological disorder, cardiac problems, lymphatic obstruction, Haematological disorders and bleeding disorders -Patients on intravenous chemotherapy. -Patients with injury on the same side of the limb.

Design outcomes

Primary

Measure	Time frame
Compare the effectiveness of Glycerine Magnesium Sulphate paste and heparinoid (thrombophob) ointment by assessing the reduction in phlebitis and pain intensity at every 24 hours on patients with peripheral intravenous therapy.Timepoint: The investigator will assess the participantâ??s phlebitis condition and grade it using Visual Infusion Phlebitis Scale (VIP) as (1,2,3,4,5)and will also assess the pain level using Numerical pain rating scale( No pain; 0, Mild pain :1-3, Moderate pain:4-6, Severe pain : 7-10), pre intervention and post intervention at 24 hours and at 48 hours.	—

Measure

Time frame

Compare the effectiveness of Glycerine Magnesium Sulphate paste and heparinoid (thrombophob) ointment by assessing the reduction in phlebitis and pain intensity at every 24 hours on patients with peripheral intravenous therapy.Timepoint: The investigator will assess the participantâ??s phlebitis condition and grade it using Visual Infusion Phlebitis Scale (VIP) as (1,2,3,4,5)and will also assess the pain level using Numerical pain rating scale( No pain; 0, Mild pain :1-3, Moderate pain:4-6, Severe pain : 7-10), pre intervention and post intervention at 24 hours and at 48 hours.

—

Secondary

Measure	Time frame
To determine association between the effectiveness of Glycerine Magnesium sulphate paste with selected demographic and clinical variable. To determine association between the effectiveness of heparinoid (thrombophob) ointment with selected demographic and clinical variable.Timepoint: The investigator will assess the participantâ??s phlebitis condition and grade it using Visual Infusion Phlebitis Scale (VIP) as (1,2,3,4,5)and will also assess the pain level using Numerical pain rating scale( No pain; 0, Mild pain :1-3, Moderate pain:4-6, Severe pain : 7-10), pre intervention and post intervention at 24 hours and at 48 hours.	—

Measure

Time frame

To determine association between the effectiveness of Glycerine Magnesium sulphate paste with selected demographic and clinical variable. To determine association between the effectiveness of heparinoid (thrombophob) ointment with selected demographic and clinical variable.Timepoint: The investigator will assess the participantâ??s phlebitis condition and grade it using Visual Infusion Phlebitis Scale (VIP) as (1,2,3,4,5)and will also assess the pain level using Numerical pain rating scale( No pain; 0, Mild pain :1-3, Moderate pain:4-6, Severe pain : 7-10), pre intervention and post intervention at 24 hours and at 48 hours.

—

Countries

India

Contacts

Public ContactMsShaly Selva Grace

College of Nursing, Christian Medical College, Vellore, Tamil Nadu, India.

florasegaran2018@gmail.com0416-2282612

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026